Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
What is the price target for ALV? ›
Based on analyst ratings, Autoliv's 12-month average price target is $134.75. What is ALV's upside potential, based on the analysts' average price target? Autoliv has 5.63% upside potential, based on the analysts' average price target.
Is Allianz a good stock to buy? ›Allianz has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
Is TipRanks worth it? ›The Premium package will likely be worth it to investors who are very interested in following along with and learning from some of the highest-performing traders and analysts. A lot of people learn best by example, so it's not hard to see why a lot of folks would be interested in the TipRanks model of investing advice.
What is analyst stock target price? ›A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a stock, they generally expect the stock price to rise.
What is the stock price prediction for Alvopetro? ›The analyst consensus target price for shares in Alvopetro Energy is CA$7.78. That is 46.55% above the last closing price of CA$5.31. Analysts covering Alvopetro Energy currently have a consensus Earnings Per Share (EPS) forecast of $0.97 for the next financial year.
Who are the competitors of ALV? ›Should you be buying Autoliv stock or one of its competitors? The main competitors of Autoliv include Aptiv (APTV), Magna International (MGA), BorgWarner (BWA), Gentex (GNTX), Icahn Enterprises (IEP), Lear (LEA), Allison Transmission (ALSN), Modine Manufacturing (MOD), Visteon (VC), and Dorman Products (DORM).
Is Allianz a stable company? ›Our consistently high ratings from independent rating agencies – including Standard & Poor's, A.M. Best, and Moody's – reflect our stability, integrity, and our strong balance sheet.
Is Allianz a good investment? ›Allianz is a financially secure company with high customer satisfaction ratings for its annuities. Allianz has the longevity common among top annuity companies, having started in 1896. It specializes in fixed index annuities and has an impressive selection of these products.
Who are the top shareholders of Allianz? ›Largest shareholders include VGTSX - Vanguard Total International Stock Index Fund Investor Shares, VTMGX - Vanguard Developed Markets Index Fund Admiral Shares, IEFA - iShares Core MSCI EAFE ETF, OAKIX - Oakmark International Fund Investor Class, HLMIX - Harding Loevner International Equity Portfolio Institutional, ...
Which is better, TipRanks or zacks? ›Zacks excels in quantitative analysis and modelling, providing proprietary earnings estimate data, valuations models, and quantitative stock ratings. But it does not have the focus on actual expert performance that TipRanks offers.
Who is the most accurate stock predictor? ›
1. AltIndex – Overall Most Accurate Stock Predictor with Claimed 72% Win Rate. From our research, AltIndex is the most accurate stock predictor to consider today. Unlike other predictor services, AltIndex doesn't rely on manual research or analysis.
Who is the best stock analyst? ›- Glenn Greene – Oppenheimer. Greene focuses on the Technology sector and has an 85% success rate for his picks. ...
- Quinn Bolton – Needham. ...
- Jason Seidl – Cowen & Co. ...
- Dan Payne – National Bank. ...
- Gerard Cassidy – RBC Capital.
- Stock to buy today: Federal Bank (₹164.60): BUY.
- Stock to buy today: PNC Infratech (₹368.35): BUY.
- Stock to buy today: Latent View Analytics (₹466.75): BUY.
- Stock to buy today: Unichem Laboratories (₹454.70): BUY.
- Stock to buy today: NCC (₹170.70): BUY.
- Stock to buy today: EIH (₹265.55): BUY.
If the target price indicates that a stock is overvalued, traders may consider selling or shorting the stock to minimise potential losses. On the other hand, if the target price suggests that a stock is undervalued, traders may see it as a chance to buy and potentially benefit from future price appreciation.
How far out are analyst price targets? ›For stock analysts, the timeline is generally 12 to 18 months, but technical traders also use price targets. For stock analysts, the purpose is to help advise investors as to where their stocks might be headed and to highlight stocks that could be very good values (or very bad ones) in the future.
What is the price target for AV stock? ›AV Stock 12 Month Forecast
Based on 7 Wall Street analysts offering 12 month price targets for Aviva plc in the last 3 months. The average price target is 517.71p with a high forecast of 584.00p and a low forecast of 420.00p. The average price target represents a 5.84% change from the last price of 489.15p.
The average price target for Virtu Financial is $22.67. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $25.00 ,the lowest forecast is $21.00. The average price target represents -1.73% Decrease from the current price of $23.07.
What is the price target for T2 biosystems? ›Based on analyst ratings, T2 Biosystems's 12-month average price target is $3.00. Currently there's no upside potential for TTOO, based on the analysts' average price target. T2 Biosystems has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.